DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced a new study demonstrating DecisionDx®-Melanoma outperforms the MSKCC nomogram...
October 5, 2023
11:00 AM
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced a new study demonstrating DecisionDx®-Melanoma outperforms the MSKCC nomogram in identifying patients at low risk of SLN positivity.